PARAMETER Study: LCZ696 Safe and Effective in Reducing Systolic and Pulse Pressure. Issue 28 (29th October 2015)

• Record Type: Journal Article
• Authors: Zarifyan, Alla
• Other Names: Williams Bryan presenter.
• Is Part Of: MD conference express. Volume 15:Issue 28(2015)
• Page Start: 17
• Page End: 17
• Publication Date: 2015-10-29
• Subjects: angiotensin receptor neprilysin inhibitor -- arterial stiffness -- central aortic systolic pressure LCZ696 -- olmesartan -- pulse pressure -- PARAMETER study; Medicine -- Congresses; 610
• DOI: 10.1177/1559897715611122
• Languages: English
• ISSNs: 1559-8977

Abstract

Results of the PARAMETER study demonstrated that the angiotensin receptor neprilysin inhibitor LCZ696 reduced central aortic systolic and pulse pressure more effectively than olmesartan in older patients with systolic hypertension and arterial stiffness. Both treatments were safe and well tolerated without significantly variability in key safety parameters between the groups.